Menu
Home
Company
About
Leadership
Board of Directors
Programs
Overview
Cannabinoid therapeutic for treating COVID-19
PAS-403 for Glioblastoma
PAS-393 for Cancer
Research: Pre-BCR antibody for Leukemia
News
Investors
Contact
AGM December 18, 2020
Skip to content
Home
/
Thomas Deckwerth, PhD
News
30
Dec 2018
Thomas Deckwerth, PhD
Dec 30, 2018
Home
Company
About
Leadership
Board of Directors
Programs
Overview
Cannabinoid therapeutic for treating COVID-19
PAS-403 for Glioblastoma
PAS-393 for Cancer
Research: Pre-BCR antibody for Leukemia
News
Investors
Contact
AGM December 18, 2020
‹
›
×